Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Public ClinicalTrials.gov record NCT02253654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind Study Evaluating Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare two different dosing methods of epoetin alfa and their effectiveness in maintaining hemoglobin levels between 10.0 to 11.0 g/dL in in patients with chronic kidney disease (CKD) receiving hemodialysis.
Study identification
- NCT ID
- NCT02253654
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 216 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2015 (Actual)
- Primary completion
- Apr 27, 2016 (Actual)
- Completion
- May 25, 2016 (Actual)
- Last update posted
- May 19, 2017
2015 – 2016
United States locations
- U.S. sites
- 36
- U.S. states
- 13
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Cerritos | California | 90703 | — |
| Research Site | Glendale | California | 91204 | — |
| Research Site | Los Angeles | California | 90022 | — |
| Research Site | Los Angeles | California | 90057 | — |
| Research Site | Montebello | California | 90640 | — |
| Research Site | Riverside | California | 92501 | — |
| Research Site | San Diego | California | 92115 | — |
| Research Site | Simi Valley | California | 93065 | — |
| Research Site | Vacaville | California | 95687 | — |
| Research Site | Whittier | California | 90606 | — |
| Research Site | Miami | Florida | 33150 | — |
| Research Site | Miami Gardens | Florida | 33169 | — |
| Research Site | Pembroke Pines | Florida | 33025 | — |
| Research Site | Macon | Georgia | 31217 | — |
| Research Site | Statesboro | Georgia | 30458 | — |
| Research Site | Merrillville | Indiana | 46410 | — |
| Research Site | Michigan City | Indiana | 46360 | — |
| Research Site | Detroit | Michigan | 48202 | — |
| Research Site | Pontiac | Michigan | 48341 | — |
| Research Site | Roseville | Michigan | 48066 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | Lincoln | Nebraska | 68510 | — |
| Research Site | Astoria | New York | 11102 | — |
| Research Site | Brooklyn | New York | 11235 | — |
| Research Site | Rosedale | New York | 11422 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Carrboro | North Carolina | 27510 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Meadville | Pennsylvania | 16335 | — |
| Research Site | Philadelphia | Pennsylvania | 19106 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | Houston | Texas | 77070 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Burlington | Vermont | 05401 | — |
| Research Site | Hampton | Virginia | 23666 | — |
| Research Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02253654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02253654 live on ClinicalTrials.gov.